Yantai Dongcheng Pharmaceutical Group Co.,Ltd.

Shenzhen Stock Exchange 002675.SZ

Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Gross Profit Margin for the year ending December 31, 2023: 41.34%

Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Gross Profit Margin is 41.34% for the year ending December 31, 2023, a -3.73% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Gross Profit Margin for the year ending December 31, 2022 was 42.94%, a 4.85% change year over year.
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Gross Profit Margin for the year ending December 31, 2021 was 40.95%, a -17.64% change year over year.
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Gross Profit Margin for the year ending December 31, 2020 was 49.73%, a -16.21% change year over year.
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Gross Profit Margin for the year ending December 31, 2019 was 59.35%, a 3.56% change year over year.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

Shenzhen Stock Exchange: 002675.SZ

Yantai Dongcheng Pharmaceutical Group Co.,Ltd.

CEO	Mr. Zhi Gang Luo
IPO Date	May 25, 2012
Location	China
Headquarters	No.7 ChangBaiShan Road
Employees	2,333
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Yantai Dongcheng Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the manufacture and sale of biochemical API, chemical medicines, proprietary Chinese medicines, and nuclide drugs products in China. It offers heparin, chondroitin sulphate, and glucosamine series products, as well as collagen, hyaluronic acid, and cytochrome C for use in the therapeutic areas of cardiovascular, oncology, urology, orthopedics, and other therapeutic areas. The company also exports its products to approximately 40 countries and regions, including the Europe, America, Asia Pacific, and internationally. Yantai Dongcheng Pharmaceutical Group Co.,Ltd. was founded in 1998 and is based in Yantai, China.

Key trends

Past 5 years